Our new study is out in Nature Communications. Using TNBC organoid mouse models, we show that necroptosis in both tumour and stromal compartments cooperatively drives effective responses to immunogenic cell death–based immunotherapy. 🔗 www.nature.com/articles/s41...
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy - Nature Communications
Most advanced triple-negative breast cancers remain resistant to immunotherapy. Here, the authors discover that RIPK1-driven necroptosis in both tumor and stromal compartments is essential for effecti...
nature.com